UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Sillajen to expand clinical design for Pexa-Vec in US
by Lee Han-soo
2020-03-05 15:57
Hanmi’s NASH treatment wins orphan drug status
by Lee Han-soo
2020-03-05 14:45
GC gets item license from regulator
by Shim Hyun-tai
2020-03-04 17:21
JW Creagene wins patent to make dendritic cell treatment
by Lee Han-soo
2020-03-04 17:20
US attorney says Daewoong used Medytox's BTX strain
by Lee Han-soo
2020-03-04 15:55
라인
Korea nods testing remdesivir in COVID-19 patients
by Kim Yun-mi
2020-03-04 13:46
GSK loses out to local drugmakers in quadrivalent flu vaccine sales
by Jeong Sae-im
2020-03-04 12:05
ImmuneMed tests new drug candidate VSF on COVID-19 patients
by Shim Hyun-tai
2020-03-03 16:59
US firm to test potential coronavirus vaccine mRNA-1273
by Kim Yun-mi
2020-03-03 15:29
Whanin to sell Gedeon Richter’s schizophrenia treatment
by Lee Han-soo
2020-03-02 16:55
라인
[Special] Allergan’s dominance at stake in Daewoong-Medytox BTX battle
by Park Gi-taek
2020-03-02 14:43
Kainos Med’s HIV drug enters final stage of phase-3 trial
by Shim Hyun-tai
2020-02-28 17:07
GSK, Clover collaborate on research for COVID-19 vaccine candidate
by Shim Hyun-tai
2020-02-28 12:25
Hanmi, GC to co-develop rare diseases treatments
by Lee Han-soo
2020-02-27 16:50
JW Shinyak launches new hand eczema treatment
by Lee Han-soo
2020-02-27 16:50
라인
FDA OKs 2 phase-3 clinical trials for Gilead's Remdesivir
by Shim Hyun-tai
2020-02-27 16:08
Alvogen Korea wins anti-bribery system certification
by Lee Han-soo
2020-02-27 12:10
Huons Global posts ₩449.4 billion in 2019 sales
by Lee Han-soo
2020-02-26 16:15
US begins to test remdesivir for COVID-19 treatment
by Kim Yun-mi
2020-02-26 15:21
Novo Nordisk’s Saxenda remains at top in obesity treatment sales
by Shim Hyun-tai
2020-02-25 18:12
-
이전
11
12
13
14
15
16
17
18
19
20
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top